Mark Andrew Wilson

NKTR

Mark Andrew Wilson serves as Chief Legal Officer at Nektar Therapeutics (NKTR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

20 trades

$430.6K

Net Position

Net Seller

$430.6K

Companies Traded

NKTR

Active Period

May 2021 – Nov 2025

20 total trades

Most Recent

Sell NKTR

Nov 25, 2025 · $34.2K

Mark Andrew Wilson's Insider Trading at Nektar Therapeutics (NKTR)

Buys

0 · $0.00

Sells

20 · $430.6K

Total Shares Bought

Total Shares Sold

157,513

NKTR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 25, 2025	Sell	630	$54.28	$34.2K	21,585
Aug 21, 2025	Sell	676	$26.59	$18.0K	20,312
May 21, 2025	Sell	9,996	$0.67	$6.7K	314,296
Feb 21, 2025	Sell	11,040	$1.01	$11.2K	324,292
Dec 26, 2024	Sell	49,962	$0.90	$44.8K	351,892
Nov 20, 2024	Sell	6,407	$1.01	$6.5K	218,856
Aug 20, 2024	Sell	5,651	$1.28	$7.2K	225,263
May 20, 2024	Sell	6,260	$1.75	$11.0K	230,414
Feb 22, 2024	Sell	7,606	$0.68	$5.2K	236,674
Nov 20, 2023	Sell	7,179	$0.49	$3.5K	243,780
Aug 17, 2023	Sell	7,221	$0.78	$5.6K	250,959
May 17, 2023	Sell	7,543	$0.72	$5.4K	257,680
Feb 17, 2023	Sell	8,275	$3.00	$24.8K	265,223
Nov 18, 2022	Sell	8,690	$3.57	$31.0K	272,498
Aug 17, 2022	Sell	3,189	$4.76	$15.2K	281,188
May 17, 2022	Sell	3,136	$3.95	$12.4K	117,939
Feb 18, 2022	Sell	3,661	$10.95	$40.1K	121,075
Nov 17, 2021	Sell	6,564	$13.16	$86.4K	86,436
Aug 18, 2021	Sell	1,910	$13.83	$26.4K	72,900
May 19, 2021	Sell	1,917	$18.30	$35.1K	74,810

Related Insiders

ROBIN HOWARD W

President & CEO

NKTRSell · Feb 18, 2026

Jonathan Zalevsky

officer: Chief R&D Officer

NKTRSell · Feb 18, 2026

Explore More Insider Trading Data

NKTR Insider Trading Activity

View all insider trades at Nektar Therapeutics

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity